461 related articles for article (PubMed ID: 32314272)
41. A novel AARS mutation in a family with dominant myeloneuropathy.
Motley WW; Griffin LB; Mademan I; Baets J; De Vriendt E; De Jonghe P; Antonellis A; Jordanova A; Scherer SS
Neurology; 2015 May; 84(20):2040-7. PubMed ID: 25904691
[TBL] [Abstract][Full Text] [Related]
42. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.
Simons C; Griffin LB; Helman G; Golas G; Pizzino A; Bloom M; Murphy JL; Crawford J; Evans SH; Topper S; Whitehead MT; Schreiber JM; Chapman KA; Tifft C; Lu KB; Gamper H; Shigematsu M; Taft RJ; Antonellis A; Hou YM; Vanderver A
Am J Hum Genet; 2015 Apr; 96(4):675-81. PubMed ID: 25817015
[TBL] [Abstract][Full Text] [Related]
43. Genetic spectrum and clinical profiles in a southeast Chinese cohort of Charcot-Marie-Tooth disease.
Chen CX; Dong HL; Wei Q; Li LX; Yu H; Li JQ; Liu GL; Li HF; Bai G; Ma H; Wu ZY
Clin Genet; 2019 Nov; 96(5):439-448. PubMed ID: 31372974
[TBL] [Abstract][Full Text] [Related]
44. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.
Pitceathly RD; Murphy SM; Cottenie E; Chalasani A; Sweeney MG; Woodward C; Mudanohwo EE; Hargreaves I; Heales S; Land J; Holton JL; Houlden H; Blake J; Champion M; Flinter F; Robb SA; Page R; Rose M; Palace J; Crowe C; Longman C; Lunn MP; Rahman S; Reilly MM; Hanna MG
Neurology; 2012 Sep; 79(11):1145-54. PubMed ID: 22933740
[TBL] [Abstract][Full Text] [Related]
45. A previously unreported NARS1 variant causes dominant distal hereditary motor neuropathy in a French family.
Theuriet J; Marte S; Isapof A; de Becdelièvre A; Konyukh M; Laureano-Figueroa SM; Latour P; Quadrio I; Maisonobe T; Antonellis A; Stojkovic T
J Peripher Nerv Syst; 2024 Jun; 29(2):275-278. PubMed ID: 38769024
[TBL] [Abstract][Full Text] [Related]
46. [A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].
Kawakami N; Komatsu K; Yamashita H; Uemura K; Oka N; Takashima H; Takahashi R
Rinsho Shinkeigaku; 2014; 54(11):911-5. PubMed ID: 25420567
[TBL] [Abstract][Full Text] [Related]
47. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene.
Roa BB; Garcia CA; Suter U; Kulpa DA; Wise CA; Mueller J; Welcher AA; Snipes GJ; Shooter EM; Patel PI; Lupski JR
N Engl J Med; 1993 Jul; 329(2):96-101. PubMed ID: 8510709
[TBL] [Abstract][Full Text] [Related]
48. A novel Lys141Thr mutation in small heat shock protein 22 (HSPB8) gene in Charcot-Marie-Tooth disease type 2L.
Nakhro K; Park JM; Kim YJ; Yoon BR; Yoo JH; Koo H; Choi BO; Chung KW
Neuromuscul Disord; 2013 Aug; 23(8):656-63. PubMed ID: 23796487
[TBL] [Abstract][Full Text] [Related]
49. Case Report: Early-Onset Charcot-Marie-Tooth 2N With Reversible White Matter Lesions Repeatedly Mimicked Stroke or Encephalitis.
Huang H; Zhang Y; Yang M; Lian B; Guo R; Cao L
Front Pediatr; 2022; 10():935721. PubMed ID: 35911843
[TBL] [Abstract][Full Text] [Related]
50. The EGR2 gene is involved in axonal Charcot-Marie-Tooth disease.
Sevilla T; Sivera R; Martínez-Rubio D; Lupo V; Chumillas MJ; Calpena E; Dopazo J; Vílchez JJ; Palau F; Espinós C
Eur J Neurol; 2015 Dec; 22(12):1548-55. PubMed ID: 26204789
[TBL] [Abstract][Full Text] [Related]
51. Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.
Higuchi Y; Hashiguchi A; Yuan J; Yoshimura A; Mitsui J; Ishiura H; Tanaka M; Ishihara S; Tanabe H; Nozuma S; Okamoto Y; Matsuura E; Ohkubo R; Inamizu S; Shiraishi W; Yamasaki R; Ohyagi Y; Kira J; Oya Y; Yabe H; Nishikawa N; Tobisawa S; Matsuda N; Masuda M; Kugimoto C; Fukushima K; Yano S; Yoshimura J; Doi K; Nakagawa M; Morishita S; Tsuji S; Takashima H
Ann Neurol; 2016 Apr; 79(4):659-72. PubMed ID: 26991897
[TBL] [Abstract][Full Text] [Related]
52. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Bort S; Nelis E; Timmerman V; Sevilla T; Cruz-Martínez A; Martínez F; Millán JM; Arpa J; Vílchez JJ; Prieto F; Van Broeckhoven C; Palau F
Hum Genet; 1997 Jun; 99(6):746-54. PubMed ID: 9187667
[TBL] [Abstract][Full Text] [Related]
53. Genotype and phenotype distribution of 435 patients with Charcot-Marie-Tooth disease from central south China.
Xie Y; Lin Z; Liu L; Li X; Huang S; Zhao H; Wang B; Zeng S; Cao W; Li L; Zhu X; Huang S; Yang H; Wang M; Hu Z; Wang J; Guo J; Shen L; Jiang H; Zuchner S; Tang B; Zhang R
Eur J Neurol; 2021 Nov; 28(11):3774-3783. PubMed ID: 34255403
[TBL] [Abstract][Full Text] [Related]
54. Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family.
Montenegro G; Powell E; Huang J; Speziani F; Edwards YJ; Beecham G; Hulme W; Siskind C; Vance J; Shy M; Züchner S
Ann Neurol; 2011 Mar; 69(3):464-70. PubMed ID: 21254193
[TBL] [Abstract][Full Text] [Related]
55. [Genetic distribution in Chinese patients with hereditary peripheral neuropathy].
Liu XX; Duan XH; Zhang S; Sun AP; Zhang YS; Fan DS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):874-883. PubMed ID: 36241230
[TBL] [Abstract][Full Text] [Related]
56. A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations.
Meyer-Schuman R; Marte S; Smith TJ; Feely SME; Kennerson M; Nicholson G; Shy ME; Koutmou KS; Antonellis A
Hum Mol Genet; 2023 Jun; 32(13):2177-2191. PubMed ID: 37010095
[TBL] [Abstract][Full Text] [Related]
57. De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
Motley WW; Palaima P; Yum SW; Gonzalez MA; Tao F; Wanschitz JV; Strickland AV; Löscher WN; De Vriendt E; Koppi S; Medne L; Janecke AR; Jordanova A; Zuchner S; Scherer SS
Brain; 2016 Jun; 139(Pt 6):1649-56. PubMed ID: 27009151
[TBL] [Abstract][Full Text] [Related]
58. Data on the effects of Charcot-Marie-Tooth disease type 2N-associated AARS missense mutation (Arg329-to-His) on the cell biological properties.
Imaizumi N; Takeuchi Y; Hirano H; Torii T; Seki Y; Morimoto T; Miyamoto Y; Sakagami H; Yamauchi J
Data Brief; 2019 Aug; 25():104029. PubMed ID: 31194127
[TBL] [Abstract][Full Text] [Related]
59. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.
Ermanoska B; Motley WW; Leitão-Gonçalves R; Asselbergh B; Lee LH; De Rijk P; Sleegers K; Ooms T; Godenschwege TA; Timmerman V; Fischbeck KH; Jordanova A
Neurobiol Dis; 2014 Aug; 68():180-9. PubMed ID: 24807208
[TBL] [Abstract][Full Text] [Related]
60. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases.
Niehues S; Bussmann J; Steffes G; Erdmann I; Köhrer C; Sun L; Wagner M; Schäfer K; Wang G; Koerdt SN; Stum M; Jaiswal S; RajBhandary UL; Thomas U; Aberle H; Burgess RW; Yang XL; Dieterich D; Storkebaum E
Nat Commun; 2015 Jul; 6():7520. PubMed ID: 26138142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
